EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru

Zully M Puyén iD, David Santos-Lázaro, Aiko N Vigo, Vidia V Cotrina, Nathaly Ruiz-Nizama, Miriam J Alarcón, Belisa Asto, Teresa Huamán, David A J Moore iD

PLOS ONE · 11.06.2024 · 19 (6) · e0304130

DOI: 10.1371/journal.pone.0304130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 11.06.2024. Verfasst von Zully M Puyén und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Referencia Nacional de Micobacterias, Instituto Nacional de Salud, Lima, Perú. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Whole Genome Sequencing, Antitubercular Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica, Dirección de Investigación de la Universidad Peruana de Ciencias Aplicadas, Newton Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whole Genome Sequencing (WGS) is a promising tool in the global fight against tuberculosis (TB). The aim of this study was to evaluate the use of WGS in routine conditions for detection of drug resistance markers and transmission clusters in a multidrug-resistant TB hot-spot area in Peru. For this, 140 drug-resistant Mycobacterium tuberculosis strains from Lima and Callao were prospectively selected and processed through routine (GenoType MTBDR sl and BACTEC MGIT) and WGS workflows, simultaneously. Resistance was determined in accordance with the World Health Organization mutation catalogue. Agreements between WGS and BACTEC results were calculated for rifampicin, isoniazid, pyrazinamide, moxifloxacin, levofloxacin, amikacin and capreomycin. Transmission clusters were determined using different cut-off values of Single Nucleotide Polymorphism differences. 100% (140/140) of strains had valid WGS results for 13 anti-TB drugs. However, the availability of final, definitive phenotypic BACTEC MGIT results varied by drug with 10–17% of invalid results for the seven compared drugs. The median time to obtain results of WGS for the complete set of drugs was 11.5 days, compared to 28.6–52.6 days for the routine workflow. Overall categorical agreement by WGS and BACTEC MGIT for the compared drugs was 96.5%. Kappa index was good (0.65≤k≤1.00), except for moxifloxacin, but the sensitivity and specificity values were high for all cases. 97.9% (137/140) of strains were characterized with only one sublineage (134 belonging to “lineage 4” and 3 to “lineage 2”), and 2.1% (3/140) were mixed strains presenting two different sublineages. Clustering rates of 3.6% (5/140), 17.9% (25/140) and 22.1% (31/140) were obtained for 5, 10 and 12 SNP cut-off values, respectively. In conclusion, routine WGS has a high diagnostic accuracy to detect resistance against key current anti-TB drugs, allowing results to be obtained through a single analysis and helping to cut quickly the chain of transmission of drug-resistant TB in Peru.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantWhole Genome SequencingAntitubercular AgentsPeruHumansPolymorphism, Single NucleotideDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsGenome, BacterialMaleFemale

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Laboratorio de Referencia Nacional de Micobacterias, Instituto Nacional de Salud, Lima, Perú.
  • Escuela de Medicina, Universidad Privada de Ciencias Aplicadas, Lima, Perú.
  • Universidad Peruana Cayetano Heredia, Lima, Perú.
  • London School of Hygiene & Tropical Medicine, London, United Kingdom.

ORCID-Profile: Zully M Puyén, David A J Moore

Förderung

  • Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica
  • Dirección de Investigación de la Universidad Peruana de Ciencias Aplicadas
  • Newton Fund

Zitieren

APA

Puyén, Z. M., Santos-Lázaro, D., Vigo, A. N., Cotrina, V. V., Ruiz-Nizama, N., Alarcón, M. J., Asto, B., Huamán, T., & Moore, D. A. J. (2024). Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru. PLOS ONE, 19(6), e0304130. https://doi.org/10.1371/journal.pone.0304130

Vancouver

Puyén ZM, Santos-Lázaro D, Vigo AN, Cotrina VV, Ruiz-Nizama N, Alarcón MJ, et al. Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru. PLOS ONE. 2024;19(6):e0304130. doi:10.1371/journal.pone.0304130

BibTeX
@article{Puyn2024,
  author = {Puyén, Zully M and Santos-Lázaro, David and Vigo, Aiko N and Cotrina, Vidia V and Ruiz-Nizama, Nathaly and Alarcón, Miriam J and Asto, Belisa and Huamán, Teresa and Moore, David A J},
  title = {Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {6},
  pages = {e0304130},
  doi = {10.1371/journal.pone.0304130}
}
Kostenlos starten →